Combination Chemotherapy in Treating Patients With Recurrent or Refractory Cervical Cancer
- Conditions
- Cervical Cancer
- Registration Number
- NCT00002813
- Lead Sponsor
- Gynecologic Oncology Group
- Brief Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells.
PURPOSE: Phase II trial to study the effectiveness of combination chemotherapy with cisplatin and vinorelbine in treating patients with refractory or recurrent squamous cell cervical cancer that has not responded to local therapy.
- Detailed Description
OBJECTIVES: I. Determine the activity of cisplatin and vinorelbine in terms of response rate, duration of response, time to treatment failure, and survival in patients with advanced, persistent, or recurrent squamous cell carcinoma of the cervix.
OUTLINE: This is a multicenter study. Patients receive vinorelbine IV over 6-10 minutes on days 1, 8, 15, and 22 and cisplatin IV over 4 hours beginning after completion of vinorelbine infusion on day 1. Courses repeat every 4 weeks in the absence of disease progression or unacceptable toxicity. Patients are followed every 3 months for 2 years and then every 6 months for 3 years.
PROJECTED ACCRUAL: A total of 28-62 patients will be accrued for this study within approximately 20 months.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Female
- Target Recruitment
- 62
Not provided
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (9)
Chao Family Comprehensive Cancer Center
πΊπΈOrange, California, United States
MBCCOP - Hawaii
πΊπΈHonolulu, Hawaii, United States
Johns Hopkins Oncology Center
πΊπΈBaltimore, Maryland, United States
CCOP - Ann Arbor Regional
πΊπΈAnn Arbor, Michigan, United States
Cancer Center of Albany Medical Center
πΊπΈAlbany, New York, United States
Comprehensive Cancer Center of Wake Forest University Baptist Medical Center
πΊπΈWinston-Salem, North Carolina, United States
CCOP - Upstate Carolina
πΊπΈSpartanburg, South Carolina, United States
Brookview Research, Inc.
πΊπΈNashville, Tennessee, United States
University of Texas - MD Anderson Cancer Center
πΊπΈHouston, Texas, United States
Chao Family Comprehensive Cancer CenterπΊπΈOrange, California, United States
